{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT04453111",
      "OrgStudyIdInfo": {
        "OrgStudyId": "#7/09.26.2018"
      },
      "Organization": {
        "OrgFullName": "Institute of Cell Therapy",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Efficacy of Bone-marrow-derived and Placenta-derived Multipotent Mesenchymal Stem / Stromal Cells for Osteoarthritis",
      "OfficialTitle": "Efficacy of Bone-marrow-derived and Placenta-derived Multipotent Mesenchymal Stem / Stromal Cells for Osteoarthritis"
    },
    "StatusModule": {
      "StatusVerifiedDate": "July 2020",
      "OverallStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "January 2, 2020",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "August 2021",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "October 2021",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "June 15, 2020",
      "StudyFirstSubmitQCDate": "June 26, 2020",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "July 1, 2020",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "July 1, 2020",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "July 7, 2020",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Institute of Cell Therapy",
        "LeadSponsorClass": "INDUSTRY"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "The Institute of Traumatology and Orthopedics of NAMS of Ukraine",
            "CollaboratorClass": "UNKNOWN"
          },
          {
            "CollaboratorName": "Kyiv City Clinical Hospital № 6",
            "CollaboratorClass": "UNKNOWN"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "To define the clinical effects of intra-articular transplantation of bone-marrow-derived (BM-MMSCs) and placenta-derived multipotent mesenchymal stem / stromal cells (P-MMSCs) for knee osteoarthritis.",
      "DetailedDescription": "Multipotent mesenchymal stem / stromal cells (MMSCs) of different origin are the novel therapeutic agents that can slow down cartilage degeneration, improve reparation and ultimately prevent joint prosthetics. MSCs are capable to direct differentiation into chondrocytes, produce cytokines and growth factors with immunomodulatory and anti-inflammatory effects, stimulate angiogenesis, as well as induce chemotaxis of endogenous progenitors. Bone marrow-derived and placenta-derived MMSCs can be considered the most promising source for cell therapy of joints disorders according to availability, safety and expected therapeutic efficacy."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Knee Osteoarthritis"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "BM-MMSCs;",
          "P-MMSCs;",
          "Hyaluronic Acid"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Non-Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignInterventionModelDescription": "Experimental: HA + stem cells therapy Experimental Group 1: three intra-articular injection of allogeneic P-MMSCs with up to 2•107cells (target dose up to 6•107 cells) with 20 mg Hyaluronic Acid at 4-weeks intervals - 15 patients Experimental Group 2: three intra-articular injection of autologous BM-MMSCs up to 2•107cells (target dose up to 6•107 cells) with 20 mg Hyaluronic Acid at 4-weeks intervals - 15 patients Control Group: three intra-articular injection of 20 mg Hyaluronic Acid, no cell therapy - 15 patients",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "45",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Hyaluronic Acid (HA) + P-MMSCs",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Experimental Group 1: Three intra-articular injection of allogeneic P-MMSCs up to 2•107cells (target dose up to 6•107 cells) with 20 mg Hyaluronic Acid at 4-weeks intervals - 15 patients",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Placenta-derived MMSCs",
                "Drug: Hyalgan 20 mg in 2 ML Prefilled Syringe"
              ]
            }
          },
          {
            "ArmGroupLabel": "Hyaluronic Acid (HA) + BM-MMSCs",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Experimental Group 2: Three intra-articular injection of autologous BM-MMSCs up to 2•107cells (target dose up to 6•107 cells) with 20 mg Hyaluronic Acid at 4-weeks intervals - 15 patients",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Bone marrow-derived MMSCs",
                "Drug: Hyalgan 20 mg in 2 ML Prefilled Syringe"
              ]
            }
          },
          {
            "ArmGroupLabel": "Hyaluronic Acid (HA)",
            "ArmGroupType": "Active Comparator",
            "ArmGroupDescription": "Three intra-articular injection of 20 mg Hyaluronic Acid - 15 patients",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Hyalgan 20 mg in 2 ML Prefilled Syringe"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Placenta-derived MMSCs",
            "InterventionDescription": "Cryopreserved placenta-derived multipotent mesenchymal stem / stromal cells",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Hyaluronic Acid (HA) + P-MMSCs"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "P-MMSCs"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "Bone marrow-derived MMSCs",
            "InterventionDescription": "Cryopreserved bone marrow-derived multipotent mesenchymal stem / stromal cells",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Hyaluronic Acid (HA) + BM-MMSCs"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "BM-MMSCs"
              ]
            }
          },
          {
            "InterventionType": "Drug",
            "InterventionName": "Hyalgan 20 mg in 2 ML Prefilled Syringe",
            "InterventionDescription": "Hyaluronic Acid 20 mg",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Hyaluronic Acid (HA)",
                "Hyaluronic Acid (HA) + BM-MMSCs",
                "Hyaluronic Acid (HA) + P-MMSCs"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "HA"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Number of participants with adverse events and changes in physical examinations, vital signs and the results of clinical lab tests.",
            "PrimaryOutcomeDescription": "Treatment-related adverse events",
            "PrimaryOutcomeTimeFrame": "12 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Physical function improvement measured by Western Ontario and McMaster Universities Arthritis Index (WOMAC).",
            "SecondaryOutcomeDescription": "Change in joint function from baseline WOMAC assessment. The WOMAC used a scoring scale of 0-4 (lower scores indicate lower levels of symptoms or physical disability). The higher the score, the higher the amount of pain, stiffness, and a high level of functional limitations.",
            "SecondaryOutcomeTimeFrame": "12 months."
          },
          {
            "SecondaryOutcomeMeasure": "Radiographic evidence. Whole-Organ Magnetic Resonance Imaging Score (WORMS)",
            "SecondaryOutcomeDescription": "Change in cartilage thickness of the knee using MRI",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Quality of Life (QOL) assessment",
            "SecondaryOutcomeDescription": "Change in scores on the QOL",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "The Visual Analog Scale (VAS) assessment",
            "SecondaryOutcomeDescription": "VAS - measure of pain intensity. The scale is most commonly anchored by \"no pain \" (score of 0) and \"worst imaginable pain\" (score of 10).",
            "SecondaryOutcomeTimeFrame": "12 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nClinical diagnosis of knee osteoarthritis.\nAge: 18 to 75 years old.\nKellgren-Lawrence Grade 2 or 3 according to X-ray imaging.\nKnee pain.\nWritten informed consent\n\nExclusion Criteria:\n\nAge <18 or >75 years of age by time of infusion.\nParticipation in an on-going investigational therapeutic or device trial 30 days of consent.\nRheumatoid arthritis.\nPsoriatic arthritis.\nJuvenile idiopathic arthritis.\nGout.\nInfectious arthritis.\nOsteomyelitis.\nOsteonecrosis.\nInflammatory arthritis.\nChondropathy.\nJoint contracture.\nArthroplasty.\nArthroscopy within 6 months prior to study entry.\nIntra-articular injection within 3 months prior to study entry.\nHormone intake.\nAntiaggregants and anticoagulants intake.\nImmunosuppressants intake.\nAllergy to hyaluronic acid.\nHistory of organ or cell transplantation.\nHematologic abnormality evidenced by hematocrit < 25%, white blood cell < 2,500/ul or platelet count < 100,000/ul.\nActive infection.\nPositive for HIV antigen.\nHistory of hepatitis B, hepatitis C.\nHistory of malignancy in the last 5 years prior to study entry.\nActive tumors.\nHistory of myocardial infarction.\nHistory of stroke.\nRenal failure with chronic hemodialysis.\nLiver Cirrhosis (ICGR 15 >30%).\nChromosomal abnormality.\nPeripheral nervous system disorders.\nCognitive or language barriers that prohibit obtaining informed consent or any study elements.\nHistory of drug abuse or alcohol abuse, or documented medical, occupational, or legal problems arising from the use of alcohol or drugs within the past 24 months.\nPregnant/nursing women or women of child-bearing potential.\nOther condition that limits lifespan to < 1 year.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "75 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Peter Nemtinov, MD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+380442079207",
            "CentralContactEMail": "nemtinov@stemcellclinic.com"
          },
          {
            "CentralContactName": "Vitalii Kyryk, MD, PhD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+380442079207",
            "CentralContactEMail": "kyryk@stemcellclinic.com"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Peter Nemtinov, MD",
            "OverallOfficialAffiliation": "Institute of Cell Therapy",
            "OverallOfficialRole": "Study Director"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Institute of Cell Therapy",
            "LocationStatus": "Recruiting",
            "LocationCity": "Kyiv",
            "LocationZip": "04073",
            "LocationCountry": "Ukraine",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Peter Nemtinov, MD",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "+380442079207",
                  "LocationContactEMail": "nemtinov@stemcellclinic.com"
                },
                {
                  "LocationContactName": "Vitalii Kyryk, PhD",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "+380442079207",
                  "LocationContactEMail": "kyryk@stemcellclinic.com"
                },
                {
                  "LocationContactName": "Evgen Goliuk, MD, PhD",
                  "LocationContactRole": "Principal Investigator"
                },
                {
                  "LocationContactName": "Roman Birsa, MD",
                  "LocationContactRole": "Principal Investigator"
                }
              ]
            }
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000010003",
            "ConditionMeshTerm": "Osteoarthritis"
          },
          {
            "ConditionMeshId": "D000020370",
            "ConditionMeshTerm": "Osteoarthritis, Knee"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000001168",
            "ConditionAncestorTerm": "Arthritis"
          },
          {
            "ConditionAncestorId": "D000007592",
            "ConditionAncestorTerm": "Joint Diseases"
          },
          {
            "ConditionAncestorId": "D000009140",
            "ConditionAncestorTerm": "Musculoskeletal Diseases"
          },
          {
            "ConditionAncestorId": "D000012216",
            "ConditionAncestorTerm": "Rheumatic Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M12078",
            "ConditionBrowseLeafName": "Osteoarthritis",
            "ConditionBrowseLeafAsFound": "Osteoarthritis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M21321",
            "ConditionBrowseLeafName": "Osteoarthritis, Knee",
            "ConditionBrowseLeafAsFound": "Knee Osteoarthritis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M3628",
            "ConditionBrowseLeafName": "Arthritis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9773",
            "ConditionBrowseLeafName": "Joint Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11249",
            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14197",
            "ConditionBrowseLeafName": "Rheumatic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5475",
            "ConditionBrowseLeafName": "Collagen Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC05",
            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionMeshList": {
        "InterventionMesh": [
          {
            "InterventionMeshId": "D000006820",
            "InterventionMeshTerm": "Hyaluronic Acid"
          }
        ]
      },
      "InterventionAncestorList": {
        "InterventionAncestor": [
          {
            "InterventionAncestorId": "D000000276",
            "InterventionAncestorTerm": "Adjuvants, Immunologic"
          },
          {
            "InterventionAncestorId": "D000007155",
            "InterventionAncestorTerm": "Immunologic Factors"
          },
          {
            "InterventionAncestorId": "D000045505",
            "InterventionAncestorTerm": "Physiological Effects of Drugs"
          },
          {
            "InterventionAncestorId": "D000055675",
            "InterventionAncestorTerm": "Viscosupplements"
          },
          {
            "InterventionAncestorId": "D000020011",
            "InterventionAncestorTerm": "Protective Agents"
          }
        ]
      },
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M9030",
            "InterventionBrowseLeafName": "Hyaluronic Acid",
            "InterventionBrowseLeafAsFound": "Autoimmunity",
            "InterventionBrowseLeafRelevance": "high"
          },
          {
            "InterventionBrowseLeafId": "M2780",
            "InterventionBrowseLeafName": "Adjuvants, Immunologic",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M9353",
            "InterventionBrowseLeafName": "Immunologic Factors",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M27448",
            "InterventionBrowseLeafName": "Viscosupplements",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M21022",
            "InterventionBrowseLeafName": "Protective Agents",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}